- Bellator 135 Results: Marcos Galvao Crowned New Bantamweight Champ
- Conor McGregor: Everything I Touch Turns To Gold
- Anderson Silva Says Another Title Run Possible If He Has The Opportunity
- Claudia Gadelha Injured, Out Of UFC Fight Night 64
- Ricardo Lamas: Conor McGregor Doesn’t Like It When The Tables Are Turned
- Cyborg’s Attempt To Make Bantamweight Back On For Next Fight
- Dana White Not Optimistic About GSP Return: He Hasn’t Been Hungry For A Long Time
- CABMMA Changes Drew Dober Loss To No Contest
Brazilian MMA Commission CABMMA Follows Nevada’s Lead, Bans TRT (But Hendo Gets One Last TUE)
Amidst the massive windfall of developments stemming from yesterday’s unanimous NSAC vote to ban all therapeutic use exemptions for TRT and the UFC’s quick decision to follow suit, it appears that Brazilian MMA Athletic Commission CABMMA has decided to do the same.
In a statement issued to SporTV, CABMMA medical director Dr. Marcio Tannure detailed the commission’s decision to ban all TRT use for fights based in Brazil:
“We discussed this subject for a long time here at CABMMA, and, as we use Nevada’s athletic commission as a model, we decided to make the same decision here in Brazil and no longer grant TRT exemptions for any fighter.” – transcribed via MMA Fighting
Tannure detailed that the commission was planning on deliberating on the matter before officially making the decision, but ultimately decided to ban the therapy outright.
The ban will start directly after March 23’s UFC Fight Night 38, which features the awaited rematch between Mauricio “Shogun” Rua and Dan Henderson. Long been known as a user of TRT, “Hendo” will be the last fighter to be granted a TUE for a UFC bout in Brazil.
When the news first broke yesterday, many thought that Brazil would be the last to fall in line. However, it appears that the exact opposite is true, as the South American MMMA hotbed has decided to rid themselves of TRT once and for all.
With Vitor Belfort stating just moments ago that the UFC forced him out of his UFC 173 against Chris Weidman, what are your thoughts on this rapidly developing storm of announcements?